Chronic pain is one of the most common reasons people turn to cannabis. Walk into any licensed dispensary in New York and you will hear it again and again: customers looking for relief from nerve pain, arthritis, old injuries, and the kind of persistent discomfort that does not respond well to other options. So what does the actual science say? In 2025 and 2026, several new analyses have given us a clearer, more honest picture, and the answer is more nuanced than either the hype or the skepticism suggests.
Here is the short version. Research suggests cannabis may offer modest relief for some types of chronic pain, with the strongest evidence pointing toward nerve-related pain. The benefits tend to be real but small, and they come with side effects worth understanding. Below, we walk through what the latest evidence actually shows, where it stops short, and how to think about flower selection if pain relief is what brings you to the menu.
What the 2025 Federal Evidence Review Found
The most rigorous recent look at this question comes from a living systematic review on cannabis for chronic pain, updated in 2025 by the Agency for Healthcare Research and Quality (AHRQ).[1] A living review is continuously updated as new trials are published, which makes it one of the most current and credible sources available.
The 2025 update found low- to moderate-strength evidence that certain cannabis products produced small improvements in pain compared with placebo during short-term treatment of one to six months. That benefit was most consistent for neuropathic pain, the burning, tingling, or shooting pain caused by nerve damage. The review also found that these same products were associated with a moderate to large increase in common side effects, including dizziness, sedation, and nausea.
One detail matters for anyone choosing a product. The review reported that products with a comparable THC to CBD ratio, or high-THC products, showed those small pain improvements, while products with a low THC to CBD ratio may not be associated with improved outcomes versus placebo.[1] In plain terms, the studies that showed a measurable effect generally involved meaningful amounts of THC, not CBD alone.
Why Neuropathic Pain Stands Out
Across the research, neuropathic pain keeps surfacing as the area where cannabis shows the most promise. The 2025 review noted that its evidence is currently most applicable to patients with neuropathic pain who started with moderate to severe pain levels.[1] This type of pain, which shows up in conditions like diabetic neuropathy, sciatica, and certain post-injury syndromes, often responds poorly to conventional approaches, which may be part of why cannabis has drawn so much research attention here.
It is worth being precise about the size of the effect. Studies indicate the average improvement is modest rather than dramatic. For some people that modest shift is meaningful, especially when other options have fallen short. For others it may not be enough to justify the side effects. That individual variation is a recurring theme in the data.
The Role of Terpenes in Pain Research
Beyond cannabinoids like THC and CBD, researchers are increasingly interested in terpenes, the aromatic compounds that give each strain its distinct scent and may shape its effects. A 2025 review of cannabis terpenes in chronic pain syndromes examined compounds including myrcene, beta-caryophyllene, limonene, pinene, linalool, and humulene.[2]
Early findings show these terpenes may influence pain signaling through several pathways, including activation of cannabinoid type 2 (CB2) receptors, modulation of TRP channels, and inhibition of inflammatory signaling.[2] Beta-caryophyllene is especially interesting because, unlike most terpenes, it appears to bind directly to CB2 receptors, which are involved in inflammation and pain.[3]
An important caveat: most of this terpene research comes from laboratory and animal studies rather than large human trials. The 2025 review was clear that rigorous, controlled human studies remain scarce, and that standardized formulations are still lacking.[2] So while the mechanisms are promising, it is too early to make firm claims about any single terpene for pain. This is one reason the entourage effect, the idea that cannabis compounds work better together than in isolation, remains an active area of study.
What the Research Says About Women and Pain
Cannabis use for chronic pain has been rising among women in particular. A 2024 analysis of administration trends found that smoking was the most common method women used for pain, followed by edibles, with vaporizing, tinctures, and topicals making up smaller shares.[4] The same body of research points to sex-based differences in how people respond to cannabis, which is an area scientists are still working to understand. The takeaway is not that cannabis works differently for everyone in unpredictable ways, but that personal factors genuinely matter, and a one-size-fits-all approach rarely fits.
How to Think About Flower Selection
If chronic pain is what brings you to the menu, the research points to a few practical principles. None of this is medical advice, but it can help you have a more informed conversation with a healthcare provider and a budtender.
| What to consider | Why it matters |
|---|---|
| Look past THC percentage | The highest-THC flower is not automatically the most effective for pain. The full profile matters more. |
| Check the terpene profile | Caryophyllene and myrcene appear most often in pain research, so they are worth noting on a label. |
| Note the THC to CBD ratio | Studies showing pain benefit generally involved meaningful THC, not CBD-only products. |
| Start low and go slow | Lower doses reduce the risk of side effects like dizziness and sedation while you learn your response. |
Greenline's strains feature detailed terpene and cannabinoid information so you can match these principles to what is actually on the shelf. For example, King Kong carries pinene, caryophyllene, and linalool, while Deep Space pairs caryophyllene with myrcene. Both are worth a look if you want to apply what the terpene research suggests. If you are newer to cannabis, our guide to low-dose THC is a useful companion to the "start low and go slow" principle.
What the Research Does Not Say
Honesty matters here, so a few cautions are in order. The evidence does not show cannabis is a cure for chronic pain, and it does not establish long-term benefit, since most of the strongest trials covered only one to six months.[1] The side effect profile is real, and cannabis can interact with other medications. Pregnant or breastfeeding individuals, people with a history of psychosis, and anyone managing a serious health condition should be especially cautious and talk with a qualified clinician first.
The most accurate summary is this: for some people with chronic pain, particularly neuropathic pain, research suggests cannabis may provide modest, meaningful relief, while for others the benefit may be small or outweighed by side effects. That is not a flashy conclusion, but it is an honest one, and it puts you in a better position to make a decision that fits your situation.
Frequently Asked Questions
Does cannabis help with chronic pain?
Research suggests cannabis may offer modest relief for some types of chronic pain, particularly neuropathic (nerve-related) pain. A 2025 federal evidence review found low- to moderate-strength evidence that certain cannabis products produced small improvements in pain over short-term use of one to six months, alongside an increase in side effects such as dizziness, sedation, and nausea. The evidence is strongest for neuropathic pain and weaker for other pain types.
What THC to CBD ratio is studied for chronic pain?
The 2025 federal living review found that products with a comparable THC to CBD ratio, or high-THC products, showed small improvements in pain versus placebo in short-term studies. Products with a low THC to CBD ratio may not be associated with improved pain outcomes versus placebo. These findings come with meaningful limitations, and individual responses vary.
Which terpenes are being studied for pain?
A 2025 review highlighted terpenes including myrcene, beta-caryophyllene, limonene, pinene, linalool, and humulene as compounds of interest for pain. Early research suggests they may act through cannabinoid type 2 (CB2) receptors, TRP channels, and anti-inflammatory pathways. Most of this evidence comes from laboratory and animal studies, and rigorous human trials are still limited.
Is cannabis for chronic pain legal in New York?
Adults 21 and older can purchase cannabis from licensed dispensaries in New York. New York also operates a medical cannabis program for certified patients. Anyone considering cannabis for a chronic pain condition should speak with a qualified healthcare provider, especially if they take other medications.
How should I choose flower if I am interested in pain relief?
Start by looking at the full label rather than THC percentage alone. Consider the terpene profile, the THC to CBD ratio, and start with a low dose to see how you respond. Strains rich in caryophyllene and myrcene are commonly discussed in pain research. Speaking with a knowledgeable budtender and a healthcare provider can help you make an informed choice.
References
- McDonagh MS, Morasco BJ, Wagner J, et al. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2025 Update. Rockville, MD: Agency for Healthcare Research and Quality (US); 2025. NCBI Bookshelf NBK618040 (PMID: 40956916)
- Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain Syndromes. Pharmaceuticals (Basel). 2025;18(8):1100. doi:10.3390/ph18081100
- Bahi A, Al Mansouri S, Al Memari E, et al. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiology & Behavior. 2014;135:119-124. PubMed:24930711
- Emerging trends in cannabis administration for women with chronic pain. Mental Health Science. 2024;2(4):e88. doi:10.1002/mhs2.88
This article is for educational purposes only and is not medical advice. Cannabis affects everyone differently. Talk with a qualified healthcare provider before using cannabis for a chronic pain condition, especially if you take other medications. For use only by adults 21 and older. Keep out of reach of children.
Explore terpene-rich flower from New York
Browse Our Strains